P
23.22
0.35 (1.53%)
| Previous Close | 22.87 |
| Open | 22.85 |
| Volume | 1,097,615 |
| Avg. Volume (3M) | 744,550 |
| Market Cap | 2,856,095,488 |
| Price / Earnings (TTM) | 165.86 |
| Price / Earnings (Forward) | 24.21 |
| Price / Sales | 1.42 |
| Price / Book | 3.95 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2026 |
| Profit Margin | 0.87% |
| Operating Margin (TTM) | 1.09% |
| Diluted EPS (TTM) | 0.120 |
| Quarterly Revenue Growth (YOY) | 15.60% |
| Quarterly Earnings Growth (YOY) | 41.40% |
| Total Debt/Equity (MRQ) | 0.77% |
| Current Ratio (MRQ) | 1.88 |
| Operating Cash Flow (TTM) | 118.36 M |
| Levered Free Cash Flow (TTM) | 110.63 M |
| Return on Assets (TTM) | 1.21% |
| Return on Equity (TTM) | 3.01% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Bearish |
| Health Information Services (Global) | Bearish | Bearish | |
| Stock | Privia Health Group, Inc. | Mixed | Bullish |
AIStockmoo Score
-0.1
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | 1.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -0.13 |
|
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 6.71% |
| % Held by Institutions | 100.20% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Rubicon Founders Llc | 30 Sep 2025 | 5,773,522 |
| Riverbridge Partners Llc | 31 Dec 2025 | 4,583,590 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 34.00 (Canaccord Genuity, 46.43%) | Buy |
| Median | 31.00 (33.51%) | |
| Low | 23.00 (Barclays, -0.95%) | Hold |
| Average | 30.56 (31.61%) | |
| Total | 8 Buy, 1 Hold | |
| Avg. Price @ Call | 23.60 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| RBC Capital | 09 Jan 2026 | 31.00 (33.51%) | Buy | 23.04 |
| Stephens & Co. | 04 Dec 2025 | 32.00 (37.81%) | Buy | 24.00 |
| BMO Capital | 13 Nov 2025 | 30.00 (29.20%) | Buy | 23.75 |
| JP Morgan | 13 Nov 2025 | 33.00 (42.12%) | Buy | 23.75 |
| Canaccord Genuity | 12 Nov 2025 | 34.00 (46.43%) | Buy | 24.22 |
| Barclays | 10 Nov 2025 | 23.00 (-0.95%) | Hold | 23.41 |
| Truist Securities | 10 Nov 2025 | 31.00 (33.51%) | Buy | 23.41 |
| Citizens | 07 Nov 2025 | 31.00 (33.51%) | Buy | 23.43 |
| Evercore ISI Group | 07 Nov 2025 | 30.00 (29.20%) | Buy | 23.43 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 22 Jan 2026 | Announcement | Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26 |
| 06 Nov 2025 | Announcement | Privia Health Reports Third Quarter 2025 Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |